Day: March 1, 2021

FDA Approves Libtayo as Monotherapy for Advanced NSCLC

Libtayo | Lung Cancer
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]